Exogen Biotechnology Overview

  • Founded
  • 2012
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Exogen Biotechnology General Information


Owner and operator of a company providing technologies to monitor DNA damage and to assess DNA repair capacities. The company provides services for individuals, organizations and research institutes to monitor damage to their DNA and to assess their DNA repair capacities for the purposes of personalized and preventive health care.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Healthcare
Primary Office
  • QB3 East Bay Innovation Center
  • 820 Heinz Avenue
  • Berkeley, CA 94710
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exogen Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Oct-2017 Completed Out of Business
3. Product Crowdfunding 26-Mar-2014 00000 Completed Startup
2. Grant $70K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Exogen Biotechnology’s complete valuation and funding history, request access »

Exogen Biotechnology Executive Team (3)

Name Title Board Seat Contact Info
Christian Keller Chief Executive Officer
Jonathan Tang Ph.D Co-Founder & Chief Technology Officer
Sylvain Costes Ph.D Co-Founder & CSO
To view Exogen Biotechnology’s complete executive team members history, request access »